Experience
Grünenthal GmbH
Teva Pharmaceuticals
Represented Grünenthal in ANDA litigations against several defendants relating to abuse-deterrent formulations of OxyContin®and Opana®.
Grünenthal GmbH v. Teva Pharmaceuticals, 1:12-cv-08060, S.D.N.Y., Judges Griesa, Daniels, Gorenstein
Neste Oil Oyj v. Dynamic Fuels, LLC
Neste Oil
Delavau, LLC, v. J.M. Huber Corporation
J.M. Huber Corp.
Apotex Inc. v. Senju Pharmaceutical
Senju Pharmaceuticals Co. Ltd.
Acura Pharmaceuticals v. Sandoz
Acura Pharmaceuticals Incorporated
Bridgestone Firestone v. FleetPride
Bridgestone Firestone
Ferring B.V. v. Allergan, Inc.
Ferring B.V.
Settlement achieved for Boeing
The Boeing Company
BTG International Ltd.
Shionogi Pharmaceuticals v. Apotex/Sandoz
Shionogi Pharmaceuticals
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.